 |
Journal articles
Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage.
Abstract : The aim of the study was to analyze the impact of MenBvac, an outer membrane vesicle (OMV) vaccine against P1.7,16 strains, on meningococcal carriage. During a B:14:P1.7,16/ST-32 outbreak in Normandy (France), children aged 1-7 years were randomly selected to participate in the study. Among the 1082 volunteers, there were 17 Neisseria meningitidis carriers (carriage rate of 1.57%). MenBvac vaccination appeared associated with lower carriage rate, i.e., 0.31% among the vaccinated children versus 2.10% among the non-vaccinated (p=0.03). The beneficial effect on carriage was observed regardless of the strain serogroup. OMV-vaccinated mice also showed reduction of bacterial acquisition of OMV-homolog and hererolog strains in respiratory pathways after intranasal challenge. These results suggest that meningococcal OMV-based vaccines reduce meningococcal carriage and may hence confer herd immunity.
https://hal-pasteur.archives-ouvertes.fr/pasteur-02073842
Contributor : Marie Martin Connect in order to contact the contributor
Submitted on : Wednesday, March 20, 2019 - 11:46:18 AM
Last modification on : Thursday, April 7, 2022 - 10:10:35 AM
Contributor : Marie Martin Connect in order to contact the contributor
Submitted on : Wednesday, March 20, 2019 - 11:46:18 AM
Last modification on : Thursday, April 7, 2022 - 10:10:35 AM